Cytotoxic protein expression in natural killer cell lymphomas and in αβ and χδ peripheral T-cell lymphomas

Journal of Pathology

Volumn 183, Issue 4, 1997, Pages 432-439

  Boulland, Marie Laure ^a   Kanavaros, Panagiotis ^b   Wechsler, Janine ^a   Casiraghi, Odile ^c   Gaulard, Philippe ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Cytotoxicity; Granzyme B; NK cell lymphomas; Perforin; Peripheral T cell lymphomas; TIA 1

Indexed keywords

GRANZYME B; T LYMPHOCYTE RECEPTOR;

APOPTOSIS; ARTICLE; CYTOLYSIS; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPHOMA; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL LYMPHOMA; TARGET CELL;

GRANZYMES; HUMANS; IMMUNOENZYME TECHNIQUES; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL, PERIPHERAL; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; NEOPLASM PROTEINS; POLY(A)-BINDING PROTEINS; PORE FORMING CYTOTOXIC PROTEINS; PROTEINS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RNA-BINDING PROTEINS; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030715666     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199712)183:4<432::AID-PATH942>3.0.CO;2-4     Document Type: Article

References (43)

1. Harris NL, Jaffe ES, Stein H. et al. A revised European - American classification of lymphoid neoplasms. A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
2. Gaulard P, Bourquelot P, Kanavaros P, et al. Expression of the alpha/beta and gamma/delta T-cell receptors in 57 cases of peripheral T-cell lymphoma. Identification of a subset of γδ T-cell lymphomas. Am J Pathol 1990; 137: 617-628.
3. Stansfeld AG, Diebold J, Noel H, et al. Updated Kiel classification for lymphomas. Lancet 1988; 1: 292-293
4. Gisselbrecht C, Gaulard P, Lepage E, et al. Pleomorphic large T-cell lymphomas have a worse prognosis than diffuse large B cell lymphomas. Ann Oncol 1996; 7 (Suppl 3): 26 (Abstract).
5. Farcet JP, Gaulard P, Marolleau JP, et al. Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor γδ. Blood 1990; 75: 2213-2229.
6. Kanavaros P, Farcet JP, Gaulard P, et al, Recombinative events of the T-cell antigen receptor δ gene in peripheral T-cell lymphomas. J Clin Invest 1991; 87: 666-672.
7. Wong KF, Chan JKC, Matutes E, et al. Hepatosplenic γδ T-cell lymphoma: a distinctive aggressive lymphoma type. Am J Surg Puthol 1995; 19: 718-726.
8. Cook CB, Krenacs L, Stetler-Stevenson M, et al. Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic γδ T-cell origin. Blood 1996; 88: 4265-4274.
9. Emile JF, Boulland ML, Haouin C, et al. CDS - , CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 1996; 87: 1466-1473.
10. Kagi D, Ledermann B, Bürki K, Zinkernagel RM, Hengartner H. Lymphocyte-mediated cytotoxicity in vitro and in vivo: mechanisms and significance. Immunol Rev 1995; 146: 95-115.
11. Berke G, The CTL's kiss of death. Cell 1995; 81: 9-12.
12. Liu CC, Walsh CM, Young JDE. Perforin: structure and function, Immunol Today 1995; 16: 194-201.
13. Smyth MJ, Trapani JA. Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol Today 1995; 16: 202-206.
14. Tian Q, Streuli M, Saito H, Schlossman SF, Anderson P. A polyadenylate binding protein localized to the granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell 1991; 67: 629-639.
15. Anderson P, Nagler-Anderson C, O'Brien C, et al. A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes. J Immunol 1990; 144: 574-582.
16. Medley QG, Kedersha N, O'Brien S, et al. Characterization of GMP-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition. Proc Natl Acad Sci USA 1996; 93: 685-689.
17. Griffiths GM, Mueller C. Expression of perform and granzymes in vivo: potential diagnostic markers for activated cytotoxic cells, Immunol Today 1991; 12: 415-419.
18. Salcedo TW, Azzoni L, Wolf SF, Perussia B. Modulation of perforin and granzyme messenger RNA expression in human natural killer cells. J Immunol 1993; 151: 2511-2520.
19. Koizumi H, Liu CC, Zheng LM, et al. Expression of perforin and serine-esterases by human γ/δ T cells. J Exp Med 1991; 173: 499-502.
20. Hameed A, Olsen KJ, Chen L, Fox WM, Hruban RH, Podack ER. Immunohistochemical identification of cytotoxic lymphocytes using human perforin monoclonal antibody. Am J Pathol 1992; 140: 1025-1030.
21. Kummer JA, Kamp AM, van Katwijk M, et al. Production and characterization of monoclonal antibodies raised against recombinant human granzymes A and B and showing cross reactions with the natural proteins. J Immunol Methods 1993; 163: 77-83.
22. de Bruin PC, Kummer JA, van der Valk P, et al. Granzyme B-expressing peripheral T-cell lymphomas; neoplastic equivalents of activated cytotoxic T cells with preference for mucosa-associated lymphoid tissue (MALT) localization. Blood 1994; 84: 3785-3791.
23. Mori N, Yatabe Y, Oda K, et al. Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation. Am J Pathol 1996; 149:699-705.
24. Foss HD, Anagnostopoulos J, Araujo I, et al Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules. Blood 1996; 88: 4005-4011.
25. Jaffe ES, Chan JKC, Su IJ, et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis and epidemiology. Am J Surg Puthol 1996; 20: 103-111,
26. Cordell JL, Falini B, Erber W, et al. Immunoenzymatic labeling of antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219-229.
27. Nakazawa S, Brown AE, Maeno Y, Smith CD, Aikawa M. Malaria-induced increase of splenic gamma delta T cells in humans, monkeys and mice. Exp Parasitol 1994; 79: 391-398.
28. Viney JP, MacDonald TT, Spencer J. Gamma/delta T-cells in the gut epithelium. Gut 1990; 31: 841-844.
29. Richmond I, Pritchard G E, Ashcroft T, Corris PA, Walters EH. Distribution of γδ T-cells in the bronchial tree of smokers and non-smokers. J clin Pathol 1993; 46: 926-930.
30. Häcker G, Kromer S, Falk M, Heeg K, Wagner H, Pfeffer K. Vδ1 + subset of human γδ T cells responds to ligands expressed by EBV-infected Burkitt lymphoma cells and transformed B lymphocytes. J Immunol 1992; 149: 3984-3989.
31. Wang L, Goillot E, Tepper RI. Interleukin-10 inhibits alloreactive cytotoxic T lymphocyte generation in vivo. Cell Immunol 1994; 159: 152-159.
32. Lancki DW, Hsieh CS, Fitch FW, Mechanisms of lysis by cytotoxic T lymphocyte clones. Lytic activity and gene expression in cloned antigen-specific CD4+ and CD8+ T lymphocytes. J Immunol 1991; 146: 3242-3249.
33. Yasukawa M, Utsunomiya Y, Inoue Y, Kimura N, Fujita S. Monoclonal proliferation of CD4+ large granular lymphocytes with cytolytic activity. Br J Haematol 1995; 91: 419-420.
34. Leger-Ravet MB, Devergne O, Peuchmaur M, et al. In situ detection of activated cytotoxic cells in follicular lymphomas. Am J Pathol 1994; 144: 492-499.
35. Matutes E, Coelho E, Aguado MJ, et al. Expression of TIA-1 and TIA-2 in T-cell malignancies and T-cell lymphocytosis. J Clin Pathol 1996; 49: 154-158.
36. Weiss LM, Jaffe ES, Liu XF, Chen YY, Shibata D, Medeiros LJ. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood 1992; 79: 1789-1795.
37. Barrett TA, Gajewski TF, Danielpour D, Chang EB, Beagley KW, Bluestone JA. Differential function of intestinal intraepithelial lymphocyte subsets. J Immunol 1992; 149: 1124-1130.
38. Halstensen TS, Brandtzaeg P. Activated T lymphocytes in the celiac lesion: non-proliferative activation (CD25) of CD4+ alβ cells in the lamina propria but proliferation (Ki-67) of alβ and γ/δ cells in the epithelium. Eur J Immunol 1993; 23: 505-510.
39. Kanavaros P, Lescs MC, Briere J, et al. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993; 81: 2688-2695.
40. Oberhuber G, Vogelsang H, Stolte M, Muthenthaler S, Kummer AJ, Radaszkiewicz T. Evidence that intestinal intraepithelial lymphocytes are activated cytotoxic T cells in celiac disease hut not in giardiasis. Am J Pathol 1996; 148: 1351-1357.
41. Imai S, Sugiura M, Oikawa O, et al. Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines establish from severe chronic active EBV infection. Blood 1996; 87: 1446-1457.
42. Isaacson PG. Intestinal lymphoma and enteropathy. J Pathol 1995; 177: 111-113.
43. Brittenden J, Heys SD, Ross J, Eremin O. Natural killer cells and cancer. Cancer 1996; 77: 1226-1243.